FDA Investigator Eric W Anderson

Eric W Anderson has inspections in 7 countries as of 30 Oct 2023. Eric W Anderson has collaborated with a combinined 2955 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
30 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Australia, France, United Kingdom of Great Britain and Northern Ireland, Ireland, Germany
A Williams, Aaron L Dunbar, Acton, Adam S Freeman, Alia Dubrovsky, Alla Dubrovsky, Allen F Hall, Amanda S Zorn, Amogh Pathi, Anderson, Andersoneric, Andrea P Scott, Andrew T Todd, Angel K Sandhu, Anna L Marroquin, Arthur S Williams, Jr, Ashleigh P Wodushek, Ashley A Mutawakkil, Babatunde D Babalola, Bak, Barbara A Crowl, Blair, Bonnie E Pierson, Bryan J Love, Capri R Woolridge, Carol A Llewellyn, Carr, Catherine J Laufmann, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Celeta S Coves, Chloe Anne Leong, Christine I Shaw, Christine M Parmentier, Christopher J Lee, Christopher W Buser, Cindy W Lewis, Claudette D Brooks, Creighton T Tuzon, Cristina E Ortega, Cristina O Dar, Cynthia L Gorveatt, Daniel C Geffin, Daniel J Lahar, Daniel Velasquez, David G Whitman, Davina M Martinez, Deborah A Nebenzahl, Dorothy W Lee, Edna J Hidalgo, Edward R Kay, Elaine S Chow, Elizabeth A Dakan, Elizabeth B Griffin, Elizabeth D Connell, Emal Wahab, Emil P Wang, JD, Eric J Heinze, Felix J Marrero, Francis J Eng, Frank P Bianco, Gary L Zaharek, Gene D Arcy, Gerald N Mcgirl, DDS, Graham N Giesen, Harjap K Atwal, Harperd, Iris C Macinnes, Jacqueline M Cleary, James A Lane, James D Hildreth, James M Kewley, James M Odonnell, Janice R Small, Janice Wai, Jeffrey S Buckser, Jeffrey W Shrifter, DPM, Joan T Briones, Jocelyn T Ramos, John Cheung, Jolene S Hedgecock, Joseph A Seitz, Juan A Morales, Juanj Wu, Jude C Dikes, Juliane Kjung Lau, Kacie M Crowther, Katlin N Stubbs, Kenneth S Boehnen, Kenya Destin, Keren Arkin, Kimberly L Anderson, Kimberly Lewandowski Walker, Kingj, Kinh Q Mac, Kristin M Abaonza, L Gnnmassimia Massimilla, PharmD, Lance A Finnical, Lance M De Souza, MBA, Larkin R Buckalew, Lawton W Lum, LCDR Jennifer H Rhyu, LCDR Matthew J Morrison, Lee, Leongc, Linda Agregory Duty, Linda Linh T Nguyen, Linda S Shook, Liu, Lori S Lawless, Lorna F Jones, Lorraine N Williams, LT Mark A Chen, MPH, Lydia S Chan, Mabel M Lee, Macropolk, Maida Henesian (NMI), Maricelys Mercado, Marie K Kinkade, Mark E Chan, Mark F Chan, Mark L Collins, Mary Ewilkerson Brinsko, Mary R Hole, Matthew A Walburger, Matthew D Schnittker, Matthew M Vernon, Melanie W Pishnery, Melvin Dorin, Michael K Larson, Michelle L Tripp, Ngoc B Kelsch, Nianna C Burns, Norman Wong, Paul M Kawamoto, Peter E Baker, Phillip M Pontikos, Quynh H Strandberg, Randal Anderson, Randall F Albright, Randall J Plunkett, Raymond Souweha, Richard K Vogel, Richard L Rutherford, Ricki A Chase, Roberto Macina, Robin T Gilb, Ronald P Boyce, Ronald T Weber, Roy R Rinc, Sandra S Saniga, Sara M Richardson, Scott K Zika, Seema S Singh, Sergio Chavez (NMI), Seyyida Saterfield, Shafiq S Ahadi, Shelley H Beausoleil, Sheri S Oliver, Sherri J Jackson, Sonya L Karsik, Stanley B Eugene, BS, BME, State Agency, Stephen R Souza, Steve P Yost, Steven R Gillenwater, Terrence Gee, Thea C Grome, Timothy C Grome, Victor Spanioli, William D Bassett, Jr, William J Weis, Xiaojun Yan, Yvette E Guillermo

Eric W Anderson's Documents

Publish Date Document Type Title
June, 2011 FDA 483 Clarity Medical Systems Inc - Form 483, 2011-06-30
July, 2002 FDA 483 Apical Instruments Inc - Form 483, 2002-07-18
October, 2003 FDA 483 X-Tech Medical LLC - Form 483, 2003-10-07
January, 2003 FDA 483 Micrus Endovascular, LLC - Form 483, 2003-01-29
March, 2002 FDA 483 Cardiovention, Incorporated - Form 483, 2002-03-12
April, 2000 FDA 483 Somnus Medical Technologies, Incorporated - Form 483, 2000-04-25
July, 2003 EIR Vascular Architects - EIR, 2003-07-17
March, 2008 EIR PAREXEL International GmbH, Early Phase Clinical Unit Berlin - EIR, 2008-05-13
December, 2002 FDA 483 Intuitive Surgical, Inc. - Form 483, 2002-12-20
July, 2002 EIR Bayer Healthcare, LLC - EIR, 2002-07-11
January, 2003 EIR Micrus Endovascular, LLC - EIR, 2003-01-29
May, 2002 EIR W. L. Gore & Associates, Inc. - EIR, 2002-05-08
July, 2002 FDA 483 Bayer Healthcare, LLC - Form 483, 2002-07-11
July, 2002 FDA 483 Bayer Healthcare, LLC - Form 483, 2002-07-09
October, 2011 FDA 483 Fresenius Medical Care Renal Therapy Group, LLC - Form 483, 2011-10-24
July, 2003 FDA 483 Vascular Architects - Form 483, 2003-07-17
December, 2001 EIR Abbott Laboratories - EIR, 2001-12-17
September, 2012 FDA 483 Optovue, Inc. - Form 483, 2012-09-14
September, 2011 FDA 483 Thoratec Corp. - Form 483, 2011-09-07
December, 2003 FDA 483 Obsidian Medical Technology Inc - Form 483, 2003-11-26
March, 2001 EIR Gyrus ENT, LLC Subsidiary of Gyrus ACMI, Inc. - EIR, 2001-03-21
December, 2003 EIR Obsidian Medical Technology Inc - EIR, 2003-12-02
December, 2001 FDA 483 Abbott Laboratories - Form 483, 2001-12-17
November, 2002 FDA 483 Stellartech Research Corporation - Form 483, 2002-11-26
October, 2003 EIR X-Tech Medical LLC - EIR, 2003-10-07
April, 2003 EIR Hologic, Inc. - EIR, 2003-04-17
December, 2003 FDA 483 Coloplast Manufacturing France SAS. - Form 483, 2003-12-17
April, 2014 FDA 483 HS International Corporation - Form 483, 2014-04-02
March, 2001 FDA 483 Gyrus ENT, LLC Subsidiary of Gyrus ACMI, Inc. - Form 483, 2001-03-21
November, 2003 EIR Philips Medical Systems - EIR, 2003-11-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more